Literature DB >> 11190070

Accurate diagnosis of Helicobacter pylori with biopsy.

H M el-Zimaity1.   

Abstract

Three (author's standard) or five biopsy specimens (two antral, two corpus, one incisura) as suggested by the Sydney system (original and revised version) [figure: see text] correctly separate infected mucosa from uninfected mucosa. No combination identified correctly the presence of intestinal metaplasia to be considered reliable. If intestinal metaplasia is present, the yield of histology for H. pylori decreases despite obtaining three or four biopsy specimens in different gastric compartments. In patients with severe atrophy, if it is important to document cure of H. pylori infection, one might consider a urea breath test if histology is negative.

Entities:  

Mesh:

Year:  2000        PMID: 11190070     DOI: 10.1016/s0889-8553(05)70153-9

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  11 in total

Review 1.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  The presence of Helicobacter pylori is not associated with long-term anastomotic complications in gastric bypass patients.

Authors:  John J Kelly; Richard A Perugini; Qi L Wang; Donald R Czerniach; Julie Flahive; Philip A Cohen
Journal:  Surg Endosc       Date:  2015-01-01       Impact factor: 4.584

3.  Helicobacter pylori infection in Nigerians with dyspepsia.

Authors:  A B Olokoba; W Gashau; S Bwala; A Adamu; F K Salawu
Journal:  Ghana Med J       Date:  2013-06

4.  Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection.

Authors:  Hala El-Zimaity; Stefano Serra; Eva Szentgyorgyi; Rajkumar Vajpeyi; Amir Samani
Journal:  Can J Gastroenterol       Date:  2013-10       Impact factor: 3.522

5.  Antralization of the gastric mucosa of the incisura angularis and its gastrin expression.

Authors:  Carlos A Rubio; Edgar Jaramillo; Gaku Suzuki; Pernilla Lagergren; Gabriella Nesi
Journal:  Int J Clin Exp Pathol       Date:  2008-05-20

6.  Helicobacter pylori and precancerous conditions of the stomach: the frequency of infection in a cross-sectional study of 79 consecutive patients with chronic antral gastritis in Yaoundé, Cameroon.

Authors:  Firmin Ankouane; Dominique Noah Noah; Félicien Ntoné Enyime; Carole Menzy Ndjollé; Roger Nsenga Djapa; Bernadette Ngo Nonga; Oudou Njoya; Elie Claude Ndjitoyap Ndam
Journal:  Pan Afr Med J       Date:  2015-01-20

7.  Comparison between phenol red chromo-endoscopy and a stool rapid immunoassay for the diagnosis of Helicobacter pylori in patients with gastritis.

Authors:  Eman Abdel-Salam Ibrahim; Mohamed Abdel-Moghny Moustafa; Walaa Monis
Journal:  J Microsc Ultrastruct       Date:  2015-06-04

8.  The validity of breath collection bags method in detecting Helicobacter pylori using the novel BreathID ® Hp Lab System: a multicenter clinical study in 257 subjects.

Authors:  Vered Richter; Jeff O Gonzalez; Sabine Hazan; Gary Gottlieb; Keith Friedenberg; David Gatof; Ravi Ganeshappa; Jorge-Shmuel Delgado; Dov Abramowitz; Robert Hardi; Allan Coates; Mahmudul Haq; Nilesh Mehta; Blake A Jones; Steven F Moss; Haim Shirin
Journal:  Ther Adv Gastrointest Endosc       Date:  2019-05-30

9.  Aspirin Use Is Not Associated with the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection.

Authors:  Ji Eun Kim; Tae Jun Kim; Hyuk Lee; Yeong Chan Lee; Hwe Hoon Chung; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Jae J Kim
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

10.  Statin Use Decreases the Risk of Metachronous Gastric Cancer in Patients without Helicobacter pylori Infection.

Authors:  Tae Jin Kwon; Tae Jun Kim; Hyuk Lee; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Jae J Kim
Journal:  Cancers (Basel)       Date:  2021-03-01       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.